Glucose control levels, ischaemic brain lesions, and hyperinsulinaemia were associated with cognitive dysfunction in diabetic elderly SIR-Type 2 diabetes mellitus (DM) in the elderly is associated with impaired cognitive functioning and an increased risk of dementia [1] [2] [3] [4] . The pathogenesis of the impairment, however, remains unclear.
Our previous study indicated that the performance of a cognitive functional test was positively correlated with glycohaemoglobin, HbA 1c , which is an index of glucose control [2] . Recently, several studies suggested that use of anti-diabetic medication was associated with improved cognitive function [5] , or prevented a decline in cognitive functioning [6] .
Several reports have indicated that hyperinsulinaemia is associated with cognitive dysfunction and dementia in the general population [7, 8] . A small preliminary study reported that insulin sensitivity measured by the euglycemic insulin clamp method was inversely correlated with the cognitive functional test score [9] .
Many studies have reported that the diabetic elderly have ischaemic brain lesions such as lacunae infarctions, white matter lesions and paraventricular lesions even without neurological symptoms [10] . Several reports have also suggested that these ischaemic lesions were associated with cognitive dysfunction in the diabetic elderly [11, 12] .
In this study, we analysed the association of HbA 1c , hyperinsulinaemia and ischaemic brain changes to DMrelated cognitive dysfunction by performing an assessment of subjects' profiles including a brain imaging assessment by MRI.
Subjects and methods

Subjects
For the present study, we recruited consecutively 77 patients with type 2 DM from the Chubu Rosai Hospital's Diabetic Center. They ranged in age from 65 to 85 years. The exclusion criteria were as follows: malignancy, inflammatory disease (such as collagen disease, thyroid disease and viral hepatitis), severe microvascular complications (such as renal failure) and severe cardiovascular disease (such as myocardial infarction and unstable angina). None of the subjects had audio-visual deficiencies that would prevent them from participating in the cognitive functional assessment.
An ethical committee approved the study and all patients gave their written informed consent prior to the investigation. After giving informed consent, the cognitive functional tests were administered individually to each subject. On the day of the assessment, the subjects had breakfast as usual and the assessment was performed in the morning. Doctors performed a general physical check-up of the subjects before the assessment.
Regarding complications of DM, neuropathy, retinopathy and nephropathy were diagnosed as below: neuropathy, elevated vibratory perception thresholds or symptomatic neuropathy; retinopathy, simple retinopathy and more advanced; nephropathy, microalbuminuria and more advanced.
Cognitive tests
Cognitive function was assessed by structured performance tests that were selected to represent a broad range of cognitive domains.
(i) Mental status: the Mini-Mental State Examination (MMSE) [13] . (ii) Verbal memory (Word Recall): the Word List (a subtest of the Alzheimer's Disease Assessment Scale (ADAS) [14] ; with a score range of 0-10. (iii) Complex psychomotor skill: the Digit Symbol Substitution (DSS)
Test, a subtest of The Wechsler Adult Intelligence ScaleRevised [15] , with a score range of 0-93. (iv) Attention: The Stroop Color Word Test [16] (Japanese version); the seconds to completion are recorded and the difference between the time required to read the word card and that required to read the dot card is calculated. The wider time difference generally means a lower cognitive performance.
Well-trained psychological testers administered all four tests in the same order for all subjects.
Evaluation of subjects
Haemoglobin A 1c (HbA 1c ; reference range, 4.3-5.8%) was measured with a TOSHO Automated Glycohemoglobin Analyzer HLC-723G7 (TOSHO Co. Tokyo, Japan). Plasma insulin was assayed by radioimmunoassay.
Low-density cholesterol (LDL), high-density lipoprotein cholesterol (HDL), triglycerides (TG) and fasting blood glucose (FBG) were measured by an autoanalyser using routine enzymatic techniques. Systolic blood pressure (sBP) and diastolic blood pressure (dBP), and the body weight and height were measured before the patients took the cognitive functioning examinations.
Assessment of brain lesions
Silent cerebral infarction (SCI) was diagnosed using MRI (GE Signa Horizon, 1.5 T, Milwaukee, WI), and the criteria used for diagnosis were irregular areas of high signal intensity larger than 3 mm in diameter detected on T2-weighted images, low signal intensity areas on T1-weighted images and areas of higher intensity than that of the cerebrospinal fluid in proton density images or fluid-attenuated inversion recovery images. Lesions less than 3 mm in diameter or lesions with signal intensities similar to cerebrospinal fluid in proton images and fluid-attenuated inversion recovery images were excluded because of the high possibility that they were enlarged perivascular spaces, even if they demonstrated high signals on T2-weighted images and low signals on T1-weighted images.
A modified rating scale was used to describe the different types of hyperintense signal abnormalities surrounding the ventricules and in the deep white matter [17] . Briefly, periventricular hyperintensity (PVH) was graded as 0 = absence, 1 = 'caps' or pencil-thin lining, 2 = smooth 'halo' and 3 = irregular PVH extending into the deep white matter. Separate deep white matter hyperintense lesions (WML) were rated as 0 = absence, 1 = punctate foci, 2 = beginning confluence of foci and 3 = large confluent areas.
Data analysis
All data are presented as the mean ± standard deviation (SD). Stepwise multiple regression analysis was performed to search for the association between the performance of cognitive functional testing and the covariants. The explanatory variables used were age, sex, years of education, HbA 1c , serum insulin (log), number of SCI, WML and PVH incidents.
Results
The characteristics of the subjects are shown in Table 1 . The mean BMI was 22.5 ± 5.5 kg/m 2 , and mean HbA 1c , LDL and TG were 6.7 ± 0.8%, 123.9 ± 26.0 mg/dl and 128.8 ± 86.0 mg/dl respectively. The subjects involved in this study were not obese and were relatively tightly controlled in terms of glucose and lipid metabolism.
Stepwise multiple regression analysis indicated that the covariants that predicted the scores of the four cognitive assessments were: years of education, HbA 1c , number of SCI and WMH for DSS scores; number of SCI, HbA 1c , years of education and sex for Stroop test scores; years of education, age and HbA 1c for Word Recall counts; years of education and fasting serum insulin levels for MMSE scores ( Table 2 ).
Discussion
In this study, we assessed comprehensive variables in elderly diabetic subjects and demonstrated that several factors were associated with cognitive dysfunctioning; higher HbA 1c was associated with worse performance in DSS, Word Recall and the Stroop test; silent cerebral infarctions were associated with worse performance in DSS and the Stroop test, and hyperinsulinaemia was associated with worse performance in MMSE. Cognitive dysfunction in the diabetic elderly has recently attracted a lot of interest, but the pathogenesis of DMassociated cognitive dysfunction remains to be elucidated.
Hyperglycaemia, a striking feature of DM, is known to affect the peripheral nervous system and induce diabetic neuropathy [18] . The pathological mechanisms of diabetic neuropathy include oxidative stress mediated by free radicals and the formation of advanced glycaemia end products. Similar mechanism may contribute to the CNS pathology.
Some population-based studies have reported that hyperinsulinaemia was associated with cognitive decline or dementia [4, 6, 7] . Our previous study also showed that the insulin sensitivity measured by the euglycemic glucose clamp method was correlated with MMSE scores [9] . The mechanism of the involvement of hyperinsulinaemia in cognitive impairment is unknown to date, but several hypotheses including accelerating atherosclerosis, involvement of associated hypertension [19] [20] [21] and the alteration of amyloid β-metabolism, which plays a critical role in the pathogenesis of Alzheimer's type dementia [22, 23] , have been proposed. DM is reportedly a risk factor for SCI [24] . The association of asymptomatic brain infarctions with cognitive impairment was previously reported in some studies, including one in the diabetic elderly [13, 24, 25] . SCI may play a major role in diabetes-associated cognitive dysfunction.
This study had several limitations. First, the current analysis does not necessarily mean causal mechanism because the study design was cross-sectional. Second, the current study was performed in a single institute. Because exercise or medication can ameliorate serum glucose levels and reduce serum levels of insulin, HbA 1c and hyperinsulinaemia are potentially modifiable factors. An interventional longitudinal study may be warranted with more subjects in multiple institutes to investigate whether treatment to reduce serum glucose and insulin levels, such as exercise and/or the use of anti-diabetic medication, can ameliorate the cognitive decline.
In conclusion, we demonstrated that higher serum insulin levels were associated with cognitive dysfunction in elderly diabetic Japanese.
Key points
• To analyse the factors associated with DM-related cognitive dysfunction, we performed an assessment of subject profiles including brain imaging by MRI. 
Serum testosterone but not leptin predicts mortality in elderly men
SIR-In men ageing is associated with a gradual progressive decline of total serum testosterone concentration [1] [2] [3] [4] [5] . A substantial proportion of older men, ranging from 20% in 60 years old to 50% in 80 years old, have testosterone concentrations below the normal range of younger men [4] . Low testosterone associates with occurrence of various cardiovascular risk factors [6, 7] , and most epidemiological studies suggest that association of testosterone with coronary artery disease is either favourable or neutral [8] . Some studies have suggested that leptin is also an independent predictor of cardiovascular morbidity and mortality [9] [10] [11] , but this association has not been seen in all studies [12] . After adjustment for age, concentration of testosterone in serum is inversely correlated with intima-media thickness of the carotid artery, whereas no such association is seen between serum leptin and carotid artery thickness [12] . Thus, endogenous testosterone may have a protective role in the development of atherosclerosis in ageing men, but information on associations between testosterone and mortality or coronary heart disease is lacking. We performed a longitudinal 10-year study to clarify the association of endogenous testosterone and leptin with all-cause mortality in ageing men. The results suggest an association between low endogenous testosterone concentration and mortality in elderly men.
Subjects and methods
During the years 1991-92, a survey investigating the health of elderly men in the city of Turku, Southwest Finland, was performed. All home-dwelling male residents at the specified age and living in the defined geographical area were offered the possibility to participate; 370 men (73%) responded. Testosterone measurements were available for 310 men. We then excluded subjects with diabetes mellitus (n = 23), subjects being unable to walk at least 500 m (n = 49) and those experiencing themselves either sick or very sick at the time of the investigation (n = 51). The age of the remaining 187 men was between 71 and 72 years at the time of inclusion in the study.
The subjects visited a local health centre for medical examination, had an oral glucose tolerance test done and after an overnight fast donated serum for further studies. A list of questions such as the use of alcohol (nil/less often than once a week/at least once a week), smoking habits (yes/has finished/no) and the drug use were also asked, and the Zung self-rating depression scale questionnaire [13] was completed. The diagnosis of cardiac insufficiency and coronary heart disease, if any, was based on clinical examination and medical records. The study was approved by the local Institutional Ethics Committee. For descriptive demographic and biochemical data of the participants, please see Appendix 1 in the supplementary data on the journal's website (http://www.ageing.oupjournals.org).
The cohort was followed up for 10 years. Time and cause of death of deceased men were ascertained from the national
